Abstract
D&MD's High-Growth Diagnostics: Technology and Market Analyses of Segments experiencing Robust Growth in the Various Diagnostics Spaces market analysis report focuses on the market segments within the diagnostics industry that are currently experiencing robust growth. This also analyzes the technologies, markets (both qualitatively and quantitatively), and key companies within this space.
Table of Contents
Chapter 1: Executive Summary
- Scope of this Chapter
- Snapshot of the Market: Major Sectors of High-growth Lie in the Molecular
- Diagnostics Segment
- Segmentation of the In Vitro Diagnostics (IVD) Market Reveals the
- High-growth Segments
- Cost Per Assay Point Rankings for the Different High-growth Segments
- Regulatory Requirements in the Diagnostics Space: Impacts Adoption
- and Pace of Market Penetration of Novel Diagnostics Assays
- Approval Process-The US Marketplace
- Analyte Specific Reagents (ASRs)
- Approval Process-European Union (EU)
- Approval Process-Japan
- Market Trajectory
Chapter 2: Emerging Technology Platforms in the High-growth Diagnostics Space
- Technology Trends from D&MD's Primary Survey
- What technologies are you utilizing for Infectious Disease (ID)-including microbial and virology segments?
- What technologies are you utilizing for Oncology/Cancer Diagnostics?
- What technologies are you utilizing in the diagnostic segment of Human Genetic Targets?
- Various Emerging Technology Platforms Driving High-growth Diagnostics Market Segments
- Polymerase Chain Reaction (PCR)
- SYBR Green (Non-probe System)
- MultiCode RTx System
- Taq-Man™ (Probe System)
- HybProbe (Probe System)
- Molecular Beacons (Probe System)
- Branched DNA (bDNA)
- Transcription Mediated Amplification (TMA)
- Invader
- MultiCode® PLx
- Tag-It®
- Signature™
- Other Real-time PCR Instruments
Chapter 3: Market Analysis of the High-growth Diagnostics Space
Chapter 4: The Market Opportunity and Niches of High-growth
- Emerging Applications
- Specific Products Contributing to High-growth in Select Diagnostics Spaces
- Market Consolidation in the High-growth Diagnostics Marketplace and Newer
- Entrants into the Space
Chapter 5: Key Company Profiles and SWOT Analyses
- Abbott Diagnostics
- Bayer Healthcare Diagnostics Division
- Biosite Diagnostics
- Celera Diagnostics
- Cepheid
- DiaDexus
- DiagnoSwiss SA
- Digene Corporation
- Gen-Probe, Inc
- Innogenetics NV
- Myriad Genetics
- Quest Diagnostics
- Roche Diagnostics
- Veridex, LLC
- Other Market Participants Offering Technology, Products, and
- Services in the High-growth Diagnostics Spaces
Chapter 6: High-growth Diagnostics Markets: End-user Survey of Growth Opportunities, Market Trends, and Quantitative Analyses
- Scope and Introduction
